Bloks Group Limited — Interim / Quarterly Report 2001

Dec 12, 2000

Listed Company Information

HK PHARMA<0182> - Results Announcement Hong Kong Pharmaceutical Holdings Limited announced on 12/12/2000: (stock code: 182) Year end date: 31/3/2001 Currency: HKD (Unaudited) (Unaudited) Last Current Corresponding Period Period from 1/4/2000 from 1/4/1999 to 30/9/2000 to 30/9/1999 ('000) ('000) Turnover : 24,283 11,796 Profit/(Loss) from Operations : (1,543) (4,486) Finance cost : (2,990) (5,546) Share of Profit/(Loss) of Associates : - - Share of Profit/(Loss) of Jointly Controlled Entities : - - Profit/(Loss) after Tax & MI : (4,533) (10,058) % Change over Last Period : N/A EPS/(LPS)-Basic : (0.46 cent) (9.73 cents) -Diluted : N/A N/A Extraordinary (ETD) Gain/(Loss) : - - Profit/(Loss) after ETD Items : (4,533) (10,058) Interim Dividend per Share : Nil Nil (Specify if with other options) : - - B/C Dates for Interim Dividend : - Payable Date : - B/C Dates for (-) General Meeting : - Other Distribution for Current Period : - B/C Dates for Other Distribution : - Remarks: (1) ACCOUNTING POLICIES Basis of presentation The condensed consolidated interim financial statements are prepared in accordance with Hong Kong Statements of Standard Accounting Practice No. 25 "Interim Financial Reporting". The accounting policies and basis of preparation used in the preparation of the interim financial statements are the same as those in the annual financial statements for the year ended 31 March 2000. Comparative figures The presentation of the financial statements have been changed due to the adoption of the requirements of SSAP 1 (Revised) "Presentation of financial statements". As a result, the formats of the profit and loss account and the balance sheet have been revised and in accordance with the SSAP. Accordingly, certain comparative figures have been reclassified to conform with the current period's presentation. (2) LOSS PER SHARE The calculation of loss per share is based on the net loss from ordinary activities attributable to shareholders for the period of HK$4,533,000 (1999: loss of HK$10,058,000) and on the weighted average of 986,869,048 (1999: 103,388,173 shares which restated retrospectively as per SSAP5 after the enactment of the share consolidation in the interim period six months to 30 September 2000) ordinary shares in issue during the Period. Diluted loss per share for the six months ended 30 September 2000 and 1999 has not been presented as the effect of the assumed conversion of the share options and the convertible notes of the Company during these period were anti-dilutive. (3) DIVIDEND The directors resolved not to pay an interim dividend to the shareholders for the six months ended 30 September 2000 (1999: Nil).